Is the Blood an Alternative for Programmed Cell Death Ligand 1 Assessment in Non-Small Cell Lung Cancer?
Emmanuel Acheampong(University of Leicester), Elin S. Gray(Edith Cowan University)
Cited by 12
Related Papers
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
|Oncotarget|2015|327
Tumour PD-L1 Expression in Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
|Cells|2020|72
Abstract B044: Fragmentomic features of cell-free DNA predict late-stage melanoma treatment benefit and survival
|Clinical Cancer Research|2024|0